Based on clinical and experimental data, we have learned that hepatocytes from Z-AAT deficiency carriers can be damaged by gain-of-toxic mechanisms activated because of intracellular accumulation of Z-AAT protein [27]. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.